BACKGROUND: Ketamine is a commonly used anesthetic, but the mechanistic basis for its clinically relevant actions remains to be determined. The authors previously showed that HCN1 channels are inhibited by ketamine and demonstrated that global HCN1 knockout mice are twofold less sensitive to hypnotic actions of ketamine. Although that work identified HCN1 channels as a viable molecular target for ketamine, it did not determine the relevant neural substrate. METHODS: To localize the brain region responsible for HCN1-mediated hypnotic actions of ketamine, the authors used a conditional knockout strategy to delete HCN1 channels selectively in excitatory cells of the mouse forebrain. A combination of molecular, immunohistochemical, and cellular electrophysiologic approaches was used to verify conditional HCN1 deletion; a loss-of-righting reflex assay served to ascertain effects of forebrain HCN1 channel ablation on hypnotic actions of ketamine. RESULTS: In conditional knockout mice, HCN1 channels were selectively deleted in cortex and hippocampus, with expression retained in cerebellum. In cortical pyramidal neurons from forebrain-selective HCN1 knockout mice, effects of ketamine on HCN1-dependent membrane properties were absent; notably, ketamine was unable to evoke membrane hyperpolarization or enhance synaptic inputs. Finally, the EC50 for ketamine-induced loss-of-righting reflex was shifted to significantly higher concentrations (by approximately 31%). CONCLUSIONS: These data indicate that forebrain principal cells represent a relevant neural substrate for HCN1-mediated hypnotic actions of ketamine. The authors suggest that ketamine inhibition of HCN1 shifts cortical neuron electroresponsive properties to contribute to ketamine-induced hypnosis.
BACKGROUND:Ketamine is a commonly used anesthetic, but the mechanistic basis for its clinically relevant actions remains to be determined. The authors previously showed that HCN1 channels are inhibited by ketamine and demonstrated that global HCN1 knockout mice are twofold less sensitive to hypnotic actions of ketamine. Although that work identified HCN1 channels as a viable molecular target for ketamine, it did not determine the relevant neural substrate. METHODS: To localize the brain region responsible for HCN1-mediated hypnotic actions of ketamine, the authors used a conditional knockout strategy to delete HCN1 channels selectively in excitatory cells of the mouse forebrain. A combination of molecular, immunohistochemical, and cellular electrophysiologic approaches was used to verify conditional HCN1 deletion; a loss-of-righting reflex assay served to ascertain effects of forebrain HCN1 channel ablation on hypnotic actions of ketamine. RESULTS: In conditional knockout mice, HCN1 channels were selectively deleted in cortex and hippocampus, with expression retained in cerebellum. In cortical pyramidal neurons from forebrain-selective HCN1 knockout mice, effects of ketamine on HCN1-dependent membrane properties were absent; notably, ketamine was unable to evoke membrane hyperpolarization or enhance synaptic inputs. Finally, the EC50 for ketamine-induced loss-of-righting reflex was shifted to significantly higher concentrations (by approximately 31%). CONCLUSIONS: These data indicate that forebrain principal cells represent a relevant neural substrate for HCN1-mediated hypnotic actions of ketamine. The authors suggest that ketamine inhibition of HCN1 shifts cortical neuron electroresponsive properties to contribute to ketamine-induced hypnosis.
Authors: Rose Schnoebel; Matthias Wolff; Saskia C Peters; Michael E Bräu; Andreas Scholz; Gunter Hempelmann; Horst Olschewski; Andrea Olschewski Journal: Br J Pharmacol Date: 2005-11 Impact factor: 8.739
Authors: Xiangdong Chen; Shaofang Shu; Dylan P Kennedy; Sarah C Willcox; Douglas A Bayliss Journal: J Neurophysiol Date: 2008-10-29 Impact factor: 2.714
Authors: Phillip E Vlisides; Tarik Bel-Bahar; UnCheol Lee; Duan Li; Hyoungkyu Kim; Ellen Janke; Vijay Tarnal; Adrian B Pichurko; Amy M McKinney; Bryan S Kunkler; Paul Picton; George A Mashour Journal: Anesthesiology Date: 2017-07 Impact factor: 7.892
Authors: Charles William Carspecken; Sirisak Chanprasert; Franck Kalume; Margaret M Sedensky; Philip G Morgan Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892
Authors: Francisco J Flores; ShiNung Ching; Katharine Hartnack; Amanda B Fath; Patrick L Purdon; Matthew A Wilson; Emery N Brown Journal: J Neural Eng Date: 2015-08-13 Impact factor: 5.379
Authors: Risako Kato; Edlyn R Zhang; Olivia G Mallari; Olivia A Moody; Kathleen F Vincent; Eric D Melonakos; Morgan J Siegmann; Christa J Nehs; Timothy T Houle; Oluwaseun Akeju; Ken Solt Journal: Front Pharmacol Date: 2021-05-18 Impact factor: 5.810
Authors: Elina Cv Brinck; Elina Tiippana; Michael Heesen; Rae Frances Bell; Sebastian Straube; R Andrew Moore; Vesa Kontinen Journal: Cochrane Database Syst Rev Date: 2018-12-20